Medication for Gas and Bloating

  • For tympanites:
    Carum carvi ethan. dec. D2 dil. WELEDA, 10 drops 3x/d up to every 2 hrs
    or
    Carum carvi supp. WALA, 1x/d
    if necessary in combination with an Oxalis abdominal compress or carraway oil compresses 
    or
    Carbo Betulae cum Methano D2–D6 trit. WELEDA, 1 saltsp. (~¼ tsp.) 3x/d
    Carvon tabs. WELEDA (available in Switzlerland), 1 tab. 3x/d

  • For gastrointestinal motility disorders, e.g., during opiate therapy:
    Absinthium/Caryophylli comp. dil. WELEDA, 12 drops 3x/d

  • For tympanites with accompanying intestinal spasms:
    Nux vomica/Nicotiana comp. pill. WALA, 3 x10 pill. 

Gesellschaft Anthroposophischer Ärzte in Deutschland/GAÄD, Medizinische Sektion am Goetheanum (Hg.) Vademecum Anthroposophische Arzneimittel. 4. Aufl. München 2017. www.vademecum.org

Debus M. Medikamentöse Begleitbehandlung bei onkologischen Erkrankungen. Der Merkurstab 2009;62(4):320-325. DOI: https://doi.org/10.14271/DMS-19466-DE.



Research news

Real World Data Study: Factors Associated with Self-Reported Post/Long-COVID    
Little evidence exists on the risk factors that contribute to Post/Long-COVID (PLC). In a recent prospective study, 99 registered people reported suffering from PLC symptoms - most commonly from fatigue, dyspnea, decreased strenght, hyposmia, and memory loss. The study results show, for example, that people, who suffered from COVID-19-associated anxiety, hyposmia, or palpitations were up to eight times more at risk of developing PLC than people without these symptoms. Individuals who suffered from fatigue during COVID-19 treatment were seven times more at risk to develop PLC fatigue than those who did not show this symptom. Overall, the results revealed that 13% of the study participants who had previously suffered from COVID-19 subsequently reported having PLC. The article is published open access: 
https://doi.org/10.3390/ijerph192316124.


Further information on Anthroposophic Medicine